190 related articles for article (PubMed ID: 32840426)
21. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010.
Hoyte CO; Jacob J; Monte AA; Al-Jumaan M; Bronstein AC; Heard KJ
Ann Emerg Med; 2012 Oct; 60(4):435-8. PubMed ID: 22575211
[TBL] [Abstract][Full Text] [Related]
22. 2009 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report.
Bronstein AC; Spyker DA; Cantilena LR; Green JL; Rumack BH; Giffin SL
Clin Toxicol (Phila); 2010 Dec; 48(10):979-1178. PubMed ID: 21192756
[TBL] [Abstract][Full Text] [Related]
23. 2019 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 37th Annual Report.
Gummin DD; Mowry JB; Beuhler MC; Spyker DA; Brooks DE; Dibert KW; Rivers LJ; Pham NPT; Ryan ML
Clin Toxicol (Phila); 2020 Dec; 58(12):1360-1541. PubMed ID: 33305966
[No Abstract] [Full Text] [Related]
24. Geographic distribution of synthetic cannabinoid exposures reported to Texas poison centers.
Forrester MB; Haywood T
Am J Drug Alcohol Abuse; 2012 Nov; 38(6):603-8. PubMed ID: 22571605
[TBL] [Abstract][Full Text] [Related]
25. Marijuana Vaping in U.S. Adults: Evidence From the Behavioral Risk Factor Surveillance System.
Baldassarri SR; Camenga DR; Fiellin DA; Friedman AS
Am J Prev Med; 2020 Sep; 59(3):449-454. PubMed ID: 32684361
[TBL] [Abstract][Full Text] [Related]
26. Adolescent synthetic cannabinoid exposures reported to Texas poison centers.
Forrester MB
Pediatr Emerg Care; 2012 Oct; 28(10):985-9. PubMed ID: 23023462
[TBL] [Abstract][Full Text] [Related]
27. 2012 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 30th Annual Report.
Mowry JB; Spyker DA; Cantilena LR; Bailey JE; Ford M
Clin Toxicol (Phila); 2013 Dec; 51(10):949-1229. PubMed ID: 24359283
[TBL] [Abstract][Full Text] [Related]
28. 2017 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 35th Annual Report.
Gummin DD; Mowry JB; Spyker DA; Brooks DE; Osterthaler KM; Banner W
Clin Toxicol (Phila); 2018 Dec; 56(12):1213-1415. PubMed ID: 30576252
[TBL] [Abstract][Full Text] [Related]
29. [Cannabis--abuse and consequences].
Wøien VA; Horwitz H; Høgberg LC; Askaa B; Jürgens G
Ugeskr Laeger; 2015 Feb; 177(6):. PubMed ID: 25650575
[TBL] [Abstract][Full Text] [Related]
30. Clinical uses of cannabis and cannabinoids in the United States.
Levinsohn EA; Hill KP
J Neurol Sci; 2020 Apr; 411():116717. PubMed ID: 32044684
[TBL] [Abstract][Full Text] [Related]
31. Comparison of hospital claims and poison center data to evaluate health impact of opioids, cannabis and synthetic cannabinoids.
Wang GS; Buttorff C; Wilks A; Schwam D; Tung GJ; Banerji S; Dart RC; Pacula RL
Am J Emerg Med; 2022 Mar; 53():150-153. PubMed ID: 35051702
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Rice J; Cameron M
Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
[TBL] [Abstract][Full Text] [Related]
33. E-Cigarettes: A Review of New Trends in Cannabis Use.
Giroud C; de Cesare M; Berthet A; Varlet V; Concha-Lozano N; Favrat B
Int J Environ Res Public Health; 2015 Aug; 12(8):9988-10008. PubMed ID: 26308021
[TBL] [Abstract][Full Text] [Related]
34. The Changing Face of Synthetic Cannabinoids in Texas.
Maxwell JC
J Psychoactive Drugs; 2018; 50(4):281-286. PubMed ID: 30321129
[TBL] [Abstract][Full Text] [Related]
35. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
Mead A
Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
[TBL] [Abstract][Full Text] [Related]
36. Drug vaping applied to cannabis: Is "Cannavaping" a therapeutic alternative to marijuana?
Varlet V; Concha-Lozano N; Berthet A; Plateel G; Favrat B; De Cesare M; Lauer E; Augsburger M; Thomas A; Giroud C
Sci Rep; 2016 May; 6():25599. PubMed ID: 27228348
[TBL] [Abstract][Full Text] [Related]
37. Trends in intentional abuse or misuse of benzodiazepines and opioid analgesics and the associated mortality reported to poison centers across the United States from 2000 to 2014.
Calcaterra SL; Severtson SG; Bau GE; Margolin ZR; Bucher-Bartelson B; Green JL; Dart RC
Clin Toxicol (Phila); 2018 Nov; 56(11):1107-1114. PubMed ID: 29609498
[TBL] [Abstract][Full Text] [Related]
38. Association of cannabis, cannabidiol and synthetic cannabinoid use with mental health in UK adolescents.
Hotham J; Cannings-John R; Moore L; Hawkins J; Bonell C; Hickman M; Zammit S; Hines LA; Adara L; Townson J; White J
Br J Psychiatry; 2023 Oct; 223(4):478-484. PubMed ID: 37485911
[TBL] [Abstract][Full Text] [Related]
39. Acute Cannabis Toxicity.
Wong KU; Baum CR
Pediatr Emerg Care; 2019 Nov; 35(11):799-804. PubMed ID: 31688799
[TBL] [Abstract][Full Text] [Related]
40. Cocaine-involved suspected suicide attempts in individuals age 50 and older reported to United States Poison Centers.
Choi NG; Choi BY; Marti CN; Baker DS
Clin Toxicol (Phila); 2023 Aug; 61(8):602-610. PubMed ID: 37585276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
